Dr. Ronald B. Vender discusses the TYK2 inhibitor deucravacitinib at the World Congress of Dermatology 2023 in Singapore.
top of page
it's where dermatology lives
More Publications by © Chronicle Companies
Publishers of: The Chronicle of Skin & Allergy; Skin Spectrum Quarterly;
Women in Dermatology; The Chronicle of Cosmetic Medicine + Surgery
www.chronicle.ca www.derm.city www.skinspectrum.ca
© Chronicle Companies 2023
bottom of page
Kommentare